NO930543L - Doseringsform - Google Patents

Doseringsform

Info

Publication number
NO930543L
NO930543L NO93930543A NO930543A NO930543L NO 930543 L NO930543 L NO 930543L NO 93930543 A NO93930543 A NO 93930543A NO 930543 A NO930543 A NO 930543A NO 930543 L NO930543 L NO 930543L
Authority
NO
Norway
Prior art keywords
dosage form
dosage
Prior art date
Application number
NO93930543A
Other languages
English (en)
Other versions
NO302216B1 (no
NO930543D0 (no
Inventor
Sabine Compassi
Original Assignee
Siegfried Ag Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Ag Pharma filed Critical Siegfried Ag Pharma
Publication of NO930543D0 publication Critical patent/NO930543D0/no
Publication of NO930543L publication Critical patent/NO930543L/no
Publication of NO302216B1 publication Critical patent/NO302216B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
NO930543A 1992-02-17 1993-02-16 Farmasöytisk doseringsform med nullte ordens frigivelse av en kalsiumantagonist av dihydropyridintypen NO302216B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH46492 1992-02-17

Publications (3)

Publication Number Publication Date
NO930543D0 NO930543D0 (no) 1993-02-16
NO930543L true NO930543L (no) 1993-08-18
NO302216B1 NO302216B1 (no) 1998-02-09

Family

ID=4187618

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930543A NO302216B1 (no) 1992-02-17 1993-02-16 Farmasöytisk doseringsform med nullte ordens frigivelse av en kalsiumantagonist av dihydropyridintypen

Country Status (12)

Country Link
US (1) US5439687A (no)
JP (1) JPH061716A (no)
CA (1) CA2086989A1 (no)
CZ (1) CZ285177B6 (no)
FI (1) FI930657A (no)
HU (1) HU222252B1 (no)
IL (1) IL104192A (no)
MX (1) MX9300664A (no)
NO (1) NO302216B1 (no)
PL (1) PL172361B1 (no)
RU (1) RU2122413C1 (no)
SK (1) SK9793A3 (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
JP2676319B2 (ja) * 1994-02-09 1997-11-12 大洋薬品工業株式会社 塩酸ニカルジピンの徐放剤用製剤およびこれを利用した徐放化製剤
ES2322405T3 (es) 1996-07-08 2009-06-19 Penwest Pharmaceuticals Co. Matriz de liberacion controlada para farmacos insolubles en dosis elevadas.
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
CA2216215A1 (en) 1997-04-05 1998-10-05 Isa Odidi Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
AU762291B2 (en) 1999-09-30 2003-06-19 Penwest Pharmaceutical Co. Sustained release matrix systems for highly soluble drugs
KR100379299B1 (ko) * 2000-01-15 2003-04-10 주식회사 중외제약 펠로디핀의 가용화 방법 및 방출제어형 제제
US20030180354A1 (en) * 2001-10-17 2003-09-25 Dr. Reddy's Laboratories Limited Amlodipine maleate formulations
US6682759B2 (en) * 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
BE1014922A3 (nl) * 2002-03-01 2004-06-01 Pfizer Ltd Amlodipine als vrije base.
AU2003230805A1 (en) * 2002-04-05 2003-10-27 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
DE60228939D1 (de) * 2002-05-21 2008-10-30 Watson Lab Inc Pharmazeutische Zusammensetzung mit verzögerter Freisetzung
JP4563642B2 (ja) * 2002-05-31 2010-10-13 ワトソン ラボラトリーズ、インコーポレイテッド 医薬製剤
WO2004014448A1 (en) * 2002-08-13 2004-02-19 Medtronic, Inc. Active agent delivery system including a hydrophilic polymer, medical device, and method
ES2330653T3 (es) * 2004-01-14 2009-12-14 Lavipharm Laboratories, Inc. Dispositivo de administracion transdermica para antagonistas de calcio de tipo dihidropiridina que contienen al menos un acido graso.
PL1748762T3 (pl) * 2004-05-28 2014-05-30 Abbvie Deutschland Postać dawkowania, dająca się otrzymać ze sproszkowanej mieszaniny zawierającej nieorganiczny pigment
US20060210623A1 (en) * 2005-03-17 2006-09-21 Stach Paul E Sustained release delivery of isradipine
US20070128282A1 (en) * 2005-12-02 2007-06-07 Patel Hasmukh B Oral osmotic drug delivery system
US20070128280A1 (en) * 2005-12-02 2007-06-07 Patel Hasmukh B Oral osmotic drug delivery system
MX2009002236A (es) * 2006-08-30 2009-03-13 Jagotec Ag Formulaciones de dosis oral de liberacion controlada que comrpenden un nucleo y una o mas capas de barrera.
US20090197824A1 (en) * 2008-01-31 2009-08-06 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
WO2008095142A1 (en) * 2007-01-31 2008-08-07 Methylation Sciences International Srl Extended release pharmaceutical formulations of s-adenosylmethionine
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
JP4864024B2 (ja) * 2008-02-15 2012-01-25 エスエス製薬株式会社 時限放出製剤
KR20100069170A (ko) * 2008-12-16 2010-06-24 삼일제약주식회사 라시디핀 함유 과립 및 이를 포함하는 약학 조성물
KR101136075B1 (ko) * 2009-06-30 2012-04-17 케이엘피앤지씨앤팜 주식회사 고혈압 치료제 조성물
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
US20110027342A1 (en) * 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
PL389530A1 (pl) 2009-11-10 2011-05-23 Fabryka Maszyn FAMUR Spółka Akcyjna Sposób przeniesienia napędu w kombajnie górniczym ścianowym
WO2019004448A1 (ja) * 2017-06-30 2019-01-03 興和株式会社 医薬組成物
CN112592311B (zh) * 2021-01-03 2023-01-31 迪沙药业集团有限公司 一种硝苯地平a晶块状晶习及其控释片组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
GB8722306D0 (en) * 1987-09-22 1987-10-28 Aps Research Ltd Sustained-release formulation
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
YU45837B (sh) * 1988-01-18 1992-07-20 LEK TOVARNA FARMACEVTSKIH IN KEMIČKIH IZDELKOV d.d. Postopek za pripravo novega inkluzijskega kompleksa nikardipina oz. njegovega hidroklorida z beta-ciklodekstrinom
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung
US4893393A (en) * 1988-10-25 1990-01-16 Marshall Ben C Pipe fitting assembly tool

Also Published As

Publication number Publication date
SK9793A3 (en) 1993-09-09
NO302216B1 (no) 1998-02-09
PL297747A1 (en) 1993-11-02
HU9300424D0 (en) 1993-05-28
US5439687A (en) 1995-08-08
CZ285177B6 (cs) 1999-06-16
IL104192A (en) 1998-01-04
JPH061716A (ja) 1994-01-11
CZ8193A3 (en) 1994-01-19
RU2122413C1 (ru) 1998-11-27
MX9300664A (es) 1994-07-29
HU222252B1 (hu) 2003-05-28
FI930657A (fi) 1993-08-18
CA2086989A1 (en) 1993-08-18
HUT64694A (en) 1994-02-28
PL172361B1 (pl) 1997-09-30
FI930657A0 (fi) 1993-02-15
IL104192A0 (en) 1993-05-13
NO930543D0 (no) 1993-02-16

Similar Documents

Publication Publication Date Title
NO930543D0 (no) Doseringsform
NO942923L (no) Medikamenter
FI930882A (fi) Farmaceutiska foereningar
DK36492D0 (da) Praeparat
NO923127L (no) Farmasoeytisk kombinasjonsformulering
FI933933A (fi) Ampull
NO931831D0 (no) Farmasoeytiske blandinger
AT399443B (de) Sportschuh
NO934145D0 (no) Farmas!ytiske forbindelser
FI931251A0 (fi) Farmaceutiska foereningar
ATA236892A (de) Rotornut
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
ATA227792A (de) Sportschuh
TH13625EX (th) เอเซียโลไกลโคโปรตีน-ตัวยาคอนจูเกท
SE9200025D0 (sv) Formelement
DK59092D0 (da) Praeparat
SE9202820D0 (sv) Farmaceutisk komposition
ITMI922581A1 (it) Composizione farmaceutica
ITMI922580A1 (it) Composizione farmaceutica
PT8484T (pt) Sacarrolhas aperfeicoado
BR7200229U (pt) Doca-dupla
BR7200318U (pt) Cabide sanfonado
ATA27393A (de) Alpinski
ATA58493A (de) Lochstein
BR7200188U (pt) Hidro-cinzeiro

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees